NOGAPENDEKIN ALFA
Drug Details
- Generic Name
- NOGAPENDEKIN ALFA
- Brand Names
- N/A
- Application Number
- Sponsor
- AGC Biologics, Inc.
- NDC Codes
- 1
- Dosage Forms
- SOLUTION
- Routes
- N/A
- Active Ingredients
- NOGAPENDEKIN ALFA INBAKICEPT
Indications and Usage
1 INDICATIONS AND USAGE ANKTIVA in combination with Bacillus Calmette-Guérin (BCG) is indicated for the treatment of adult patients with BCG-unresponsive nonmuscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors. ANKTIVA is an interleukin-15 (IL-15) receptor agonist indicated with Bacillus Calmette-Guérin (BCG) for the treatment of adult patients with BCG-unresponsive nonmuscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors. ( 1 )